Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CD32b/FCGR2B Antibody (SAA0547), PE

Catalog #:   FHD97912 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, FCM, WB
Accession: P31994
Overview

Catalog No.

FHD97912

Species reactivity

Human

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

PE

Target

IGFR2, FCG2, Fc-gamma RII-b, CDw32, FcRII-b, IgG Fc receptor II-b, CD32, Fc-gamma-RIIb, Low affinity immunoglobulin gamma Fc region receptor II-b, FCGR2B, RHD97901

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

P31994

Applications

ELISA, FCM, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0547

Data Image
References

Human Fcγ-receptors selectively respond to C-reactive protein isoforms., PMID:40458392

FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs., PMID:40089806

Fc gamma receptors activate different protein kinase C isoforms in human neutrophils., PMID:39946245

The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool., PMID:39778124

A Competition-Based Strategy for the Isolation of an Anti-Idiotypic Blocking Module and Fine-Tuning for Conditional Activation of a Therapeutic Antibody., PMID:39655405

FGL2/FcγRIIB Signalling Mediates Arterial Shear Stress-Mediated Endothelial Cell Apoptosis: Implications for Coronary Artery Bypass Vein Graft Pathogenesis., PMID:39062880

ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for in vivo efficacy against SARS-CoV-2., PMID:38948747

A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia., PMID:38899695

Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding., PMID:38050338

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial., PMID:37883739

Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational study., PMID:37789648

FcγRIIB expressed on CD8+ T cells limits responsiveness to PD-1 checkpoint inhibition in cancer., PMID:37611081

FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab., PMID:37575254

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up., PMID:36972491

CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study., PMID:36929282

The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells., PMID:36822164

Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy., PMID:36685519

A Review of Margetuximab-Based Therapies in Patients with HER2-Positive Metastatic Breast Cancer., PMID:36612034

Down-regulated FcγRII expression on plasma cells is associated with the disease activity of ANCA-associated vasculitis., PMID:36111855

FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms., PMID:35858562

The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury., PMID:35784350

Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma., PMID:35610242

Role of Fcγ receptors in HER2-targeted breast cancer therapy., PMID:34992090

Erratum to: An Afucosylated Anti-CD32b Monoclonal Antibody Induced Platelet-Mediated Adverse Events in a Human Fcγ Receptor Transgenic Mouse Model and Its Potential Human Translatability., PMID:34905057

Evaluation of the FCGR2B polymorphism in children with immune thrombocytopenia., PMID:34859644

An Afucosylated Anti-CD32b Monoclonal Antibody Induced Platelet-Mediated Adverse Events in a Human Fcγ Receptor Transgenic Mouse Model and Its Potential Human Translatability., PMID:34687301

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment., PMID:34323958

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels., PMID:34192382

Blocking FcγRIIB in Smooth Muscle Cells Reduces Hypertension., PMID:33980031

Margetuximab: First Approval., PMID:33761116

Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis., PMID:33568400

FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis., PMID:33505402

Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes., PMID:33424774

IgE and mast cells: The endogenous adjuvant., PMID:33190734

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys., PMID:33188207

Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus., PMID:32945349

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma., PMID:32870269

Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies., PMID:32847974

FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients., PMID:32681817

Quantitative immunohistochemical analysis of myeloid cell marker expression in human cortex captures microglia heterogeneity with anatomical context., PMID:32678124

Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis., PMID:32613944

Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms., PMID:32222585

Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity., PMID:31940267

Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens., PMID:31866435

Mass Cytometry Analysis Reveals Complex Cell-State Modifications of Blood Myeloid Cells During HIV Infection., PMID:31824485

CD4+CD19+ conjugates favor HIV-1 infection and latency during chronic HIV-1 infection., PMID:31634199

Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial., PMID:31434737

FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding., PMID:31343409

Decreased expression of FcγRII in active Graves' disease patients., PMID:31033004

Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4Rα therapeutic antibody., PMID:30950681

Datasheet
$ 258
Product specifications
50 T 258 100 T 426

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CD32b/FCGR2B Antibody (SAA0547), PE [FHD97912]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only